Search

Author/Creator Fetterly, G.

1. 2315 A phase Ib study of the FGFR/VEGFR inhibitor dovitinib (D) combined with gemcitabine (G) and Capecitabine (C) in advanced pancreatic cancer patients. (September 2015)

Authors:
Ma, W.W.; Fetterly, G.; LeVea, C.; Zhao, Y.; Dy, G.K.; Iyer, R.; Tan, W.; Brady, W.; Whitworth, A.; Adjei, A.A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S438
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2402 Sorafenib (SOR) dose reduction attenuates its immunosuppressive effects and delays hepatocellular cancer (HCC) development in the woodchuck model of hepatitis B related HCC. (September 2015)

Authors:
Iyer, R.; Patel, P.; Buitrago, S.; Curtin, L.; Fetterly, G.; Maguire, O.; Minderman, H.; Toshkov, I.; Tennant, B.; Hutson, A.; Johnson, C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S471
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search